Atara Biotherapeutics Cash Flow Statement (2013-2026) | ATRA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-83.79M-84.66M-93.35M-88.11M18.47M-84.09M-74.68M-74.77M-71.11M-69.80M-60.70M-31.75M-19.05M-21.91M-12.69M38.01M2.39M-4.30M-36.14M-4.14M
Depreciation and Depletion (Quarter)
1.50M1.40M1.10M0.90M0.90M0.90M0.90M0.90M0.90M0.70M0.60M0.50M0.30M0.10M
Share-based Compensation (Quarter)
13.81M13.76M14.03M14.34M14.12M14.02M11.36M11.76M12.55M11.14M9.93M8.40M6.34M6.42M5.85M4.21M2.80M1.23M1.52M0.75M
Gains from Sales and Divestitures (Quarter)
0.93M1.24M1.55M0.45M1.10M1.61M2.25M0.48M1.55M2.38M3.69M1.57M0.14M0.22M0.32M0.07M0.28M0.39M0.45M0.06M
Gains from Investment Securities (Quarter)
0.52M9.35M-0.18M0.62M0.79M5.60M50.22M0.31M1.93M1.87M0.23M0.12M0.12M0.87M0.39M0.39M-0.06M
Asset Writedowns and Impairment (Quarter)
4.13M
Non-cash Items (Quarter)
55.20M49.10M12.81M0.33M0.95M0.09M0.04M35.70M31.40M23.40M29.90M23.80M7.00M0.03M8.60M0.40M0.01M0.02M0.07M
Cash from Operations (Quarter)
-61.58M-58.98M-34.27M-84.53M-63.96M-65.06M-56.88M-38.43M-52.80M-51.35M-50.41M-29.61M-10.64M-3.99M-24.47M-28.14M-7.32M-9.79M-5.70M-3.07M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.40M0.02M-1.83M-0.50M-0.31M-0.16M-0.05M1.20M1.25M1.27M1.06M1.05M-1.07M0.06M4.08M-0.26M2.07M-1.98M-0.08M0.81M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
2.30M2.30M2.44M1.59M1.40M1.40M1.25M1.21M1.20M1.21M1.21M1.39M1.33M1.23M1.10M1.79M0.24M0.04M0.05M0.03M
Change in Working Capital
Change in Receivables (Quarter)
-9.61M0.99M-0.32M-0.03M-0.39M39.97M-39.82M0.11M-0.34M33.95M1.73M-33.41M-1.09M0.15M7.39M-8.88M1.91M-0.66M-1.25M
Change in Inventory (Quarter)
1.59M3.75M2.52M-1.27M3.12M6.38M2.67M-4.77M0.16M-10.65M
Change in Account Payables (Quarter)
-5.20M4.35M0.36M-4.59M1.20M-1.38M-4.45M-1.89M-0.89M2.46M-2.81M-0.83M2.40M-3.11M2.22M-2.98M-0.08M-0.98M-0.19M0.51M
Change in Accured Expenses (Quarter)
-6.64M3.82M6.01M-8.77M-0.06M14.43M-3.53M-0.61M-4.49M5.71M-6.75M-5.81M1.56M-6.20M-2.06M-1.99M0.55M-3.08M-0.80M-0.17M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
-2.01M2.62M-2.06M-0.65M0.79M-6.92M-1.23M2.96M-9.99M7.56M-13.18M-0.44M-6.80M-0.82M7.60M-0.01M0.01M-0.28M
Investing Activities
Capital Expenditures (Quarter)
2.06M-2.40M8.72M1.19M-1.06M-0.10M0.03M0.40M-0.29M-0.09M0.11M0.13M0.03M0.09M
Sales of Property, Plant and Equipment (Quarter)
0.04M0.56M
Change in Acquisitions & Divestments (Quarter)
98.76M70.94M54.52M89.25M77.14M75.90M50.68M62.30M65.72M70.70M9.99M14.84M7.22M3.00M3.47M17.20M0.00M7.88M
Cash from Investing Activities (Quarter)
31.89M1.19M-24.32M60.22M31.83M59.70M51.22M-6.01M49.48M70.45M9.94M14.72M7.20M-16.66M3.38M17.20M-5.07M-2.42M8.44M
Financing Activities
Other financing activities (Quarter)
-0.10M-0.05M30.76M-0.01M
Cash from Financing Activities (Quarter)
2.45M47.14M51.47M19.85M1.16M-0.21M32.29M0.23M0.47M-0.21M1.51M24.14M-0.32M35.79M-0.33M-0.25M15.30M1.05M-0.00M2.95M
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
-27.24M-10.65M-7.12M-4.46M-30.98M-5.57M26.63M-44.20M-2.84M18.89M-38.95M9.25M-3.77M15.14M-21.42M-11.19M2.92M-11.16M2.74M-0.12M
Free Cash Flow (Quarter)
-63.64M-56.58M-42.99M-85.72M-62.91M-64.96M-56.91M-38.83M-52.51M-51.26M-50.52M-29.74M-10.67M-3.99M-24.56M-28.14M-7.32M-9.79M-5.70M-3.07M
Net Cash Flow (Quarter)
-27.24M-10.65M-7.12M-4.46M-30.98M-5.57M26.63M-44.20M-2.84M18.89M-38.95M9.25M-3.77M15.14M-21.42M-11.19M2.92M-11.16M2.74M-0.12M